HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Brown Selected Research

Pharmaceutical Preparations

8/2007PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
5/2007Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: a pilot study.
1/2006CytoregR inhibits growth and proliferation of human adenocarcinoma cells via induction of apoptosis.
4/2002Identification of a dup(5)(p15.3) by multicolor banding.
7/2001MMPI Profile as an Outcome "Predictor" in the Treatment of Noncancer Pain Patients Utilizing Intraspinal Opioid Therapy.
10/2000Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.
5/2000Effect of reserpine treatment on low-density lipoproteins in arterial wall and internal organs of rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Brown Research Topics

Disease

25Neoplasms (Cancer)
11/2021 - 01/2000
13Breast Neoplasms (Breast Cancer)
01/2022 - 07/2000
8Infections
01/2020 - 06/2000
7Inflammation (Inflammations)
01/2021 - 02/2004
4Carcinoma (Carcinomatosis)
01/2020 - 06/2000
3Prostatic Neoplasms (Prostate Cancer)
03/2020 - 04/2013
3Infertility (Sterility)
08/2013 - 01/2007
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2013 - 10/2004
3Neoplasm Metastasis (Metastasis)
04/2013 - 07/2000
3Pain (Aches)
07/2001 - 12/2000
3Osteoporosis
01/2001 - 02/2000
2Necrosis
01/2021 - 01/2005
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2020 - 10/2019
2COVID-19
01/2020 - 01/2020
2Myocardial Infarction
10/2017 - 10/2004
2Hematologic Neoplasms (Hematological Malignancy)
10/2017 - 04/2012
2Botulism
03/2011 - 04/2010
2Chronic Disease (Chronic Diseases)
10/2007 - 06/2007
2Atherosclerosis
08/2007 - 05/2000
2Endometriosis
07/2007 - 01/2007
2Carcinogenesis
02/2007 - 06/2000
2Systemic Vasculitis
04/2004 - 02/2004
2Hepatoblastoma
01/2004 - 11/2000
2Hypotension (Low Blood Pressure)
01/2003 - 03/2001
2Wounds and Injuries (Trauma)
08/2001 - 12/2000
1Cytopenia
01/2022
1Microsatellite Instability
11/2021
1Cough
02/2021
1Brain Ischemia (Cerebral Ischemia)
02/2020
1Reperfusion Injury
02/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Cerebral Infarction
10/2019
1Neuroinflammatory Diseases
10/2019
1Brain Injuries (Brain Injury)
10/2019

Drug/Important Bio-Agent (IBA)

7Pharmaceutical PreparationsIBA
08/2007 - 05/2000
4Biomarkers (Surrogate Marker)IBA
11/2021 - 08/2007
4Adrenal Cortex Hormones (Corticosteroids)IBA
04/2002 - 02/2000
3Hormones (Hormone)IBA
01/2022 - 12/2019
3Diphosphonates (Bisphosphonates)IBA
12/2021 - 02/2000
3Bevacizumab (Avastin)FDA Link
01/2020 - 01/2017
3Zoledronic Acid (Zometa)FDA Link
01/2018 - 06/2011
3Danazol (Azol)FDA LinkGeneric
07/2007 - 03/2000
3Cisplatin (Platino)FDA LinkGeneric
10/2004 - 10/2000
2EnzymesIBA
01/2021 - 06/2000
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 04/2004
2Docetaxel (Taxotere)FDA Link
03/2020 - 12/2019
2rhodiolosideIBA
02/2020 - 10/2019
2Complement C3 (C3 Complement)IBA
02/2020 - 10/2019
2Indicators and Reagents (Reagents)IBA
01/2020 - 11/2009
2Warfarin (Coumadin)FDA LinkGeneric
10/2017 - 03/2001
2AnticoagulantsIBA
10/2017 - 03/2001
2Focal Adhesion Protein-Tyrosine KinasesIBA
12/2016 - 01/2016
2Proteins (Proteins, Gene)FDA Link
01/2016 - 06/2001
2Cell-Free Nucleic AcidsIBA
01/2012 - 04/2011
2DNA (Deoxyribonucleic Acid)IBA
01/2012 - 04/2011
2Messenger RNA (mRNA)IBA
01/2012 - 04/2001
2Botulinum Toxins (Botulinum Toxin)IBA
03/2011 - 04/2010
2LigandsIBA
01/2009 - 08/2007
2Biological ProductsIBA
08/2007 - 04/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2005 - 04/2004
2C-Reactive ProteinIBA
05/2004 - 04/2004
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
04/2004 - 02/2004
23,4,3',4'-tetrachloroazobenzeneIBA
01/2004 - 07/2003
2rofecoxib (Vioxx)FDA Link
01/2001 - 12/2000
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2000 - 07/2000
2Strontium-90IBA
07/2000 - 01/2000
1Epidermal Growth Factor (EGF)IBA
01/2022
1abemaciclibIBA
01/2022
1AerosolsIBA
02/2021
1EndoglinIBA
01/2021
1Angiopoietin-2IBA
01/2021
1Fatty Acids (Saturated Fatty Acids)IBA
01/2021
1ImmunosorbentsIBA
01/2021
1SulfamethoxazoleFDA LinkGeneric
01/2020
1Gentamicins (Gentamicin)FDA LinkGeneric
01/2020
1GemcitabineFDA Link
01/2020
1Ciprofloxacin (Cipro)FDA LinkGeneric
01/2020
1pazopanibFDA Link
01/2020
1Meropenem (Merrem)FDA LinkGeneric
01/2020
1Tetracycline (Achromycin)FDA LinkGeneric
01/2020
1Trimethoprim (Proloprim)FDA LinkGeneric
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1PlatinumIBA
01/2020
1Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link
01/2020
1AndrogensIBA
12/2019
1Neuroprotective AgentsIBA
10/2019
1Peptides (Polypeptides)IBA
07/2019
1Aldehyde DehydrogenaseIBA
07/2019

Therapy/Procedure

22Therapeutics
01/2022 - 02/2000
7Drug Therapy (Chemotherapy)
07/2019 - 11/2000
6Radiotherapy
07/2019 - 10/2005
3Palliative Care (Palliative Therapy)
12/2014 - 06/2007
3Cell Transplantation
10/2013 - 02/2011
2Adjuvant Chemotherapy
01/2018 - 04/2017
2Terminal Care (Care, Terminal)
12/2014 - 06/2007
2Cesarean Section (Caesarean Section)
01/2013 - 03/2001
2Transplantation
05/2011 - 02/2011
2Liver Transplantation
01/2004 - 11/2000
2Analgesia
01/2003 - 01/2001
1Personal Protective Equipment
01/2020